Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New insulin study aims to speed up blood sugar control in chinese diabetes patients

NCT ID NCT04698018

First seen Dec 08, 2025 · Last updated May 22, 2026 · Updated 19 times

Summary

This study looked at how quickly a fast-acting insulin (faster aspart) enters the blood in 23 Chinese adults with type 1 or type 2 diabetes. Participants received one injection of the test insulin and one of the standard insulin NovoRapid, in random order. Blood samples were taken over 12 hours to compare how the insulins were absorbed. The goal was to see if the faster insulin works more quickly, which could help improve mealtime blood sugar control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Phase 1 Clinical Trial Centre

    Shatin, New Territories, Hong Kong, Postal Code: NA, Hong Kong

  • Phase 1 Clinical Trial Centre

    Shatin, New Territories, Hong Kong

  • Profil Institut für Stoffwechselforschung GmbH

    Neuss, 41460, Germany

Conditions

Explore the condition pages connected to this study.